In contrast with SdhA, mutations in the other subunits SdhB-D are generally associated with cancers, especially paragangliomas (PGL) and phaeochromocytomas (PCC), but also with other cancers including renal carcinoma, thyroid cancer, ovarian cancer, neuroblastoma and gastrointestinal stromal tumor [8]. This evidence concerns the gene SDHB and cancer.